Skip to content

Clinical trials

Metabolic Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Germany Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20095
20104
20131
20141
20153
20162
20171
20184
20191
20204
20212
20224
20231
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting7
Active, not recruiting6
Terminated5
Withdrawn3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.3
CENTOGENE GmbH Rostock3
Agios Pharmaceuticals, Inc.2
AstraZeneca2
Eli Lilly and Company2
German Institute of Human Nutrition2
Pfizer2
Regeneron Pharmaceuticals2
Rezolute2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases42
Glucose Metabolism Disorders11
Diabetes Mellitus, Type 210
Diabetes Mellitus9
Obesity9
Genetic Diseases, Inborn8
Endocrine System Diseases7
Metabolism, Inborn Errors7
Body Weight6
Lipid Metabolism Disorders6

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.